NCT04993781

Brief Summary

The objectives of this proposal are to evaluate the eSTEPS CDS (eSTEPS) in a cluster randomized controlled trial. The intervention includes the following: 1) A machine learning-based fall injury risk screening algorithm to improve traditional fall risk screening. 2) Provider BPA and/or Care Gap and Smart Set to provide CDS that helps primary care providers develop a tailored fall prevention exercise plan in the context of a Medicare Wellness Visit and 3) eSTEPS Patient App and exercise tools to provide older patients continued access to their interactive, tailored exercise plan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,945

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 6, 2021

Completed
1.8 years until next milestone

Study Start

First participant enrolled

June 8, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

February 11, 2026

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

June 22, 2021

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • To determine the effect of the eSTEPS intervention on the rate of falls

    Falls rate per 100 patient years

    Up to 23 months

Secondary Outcomes (2)

  • To determine the effect of the eSTEPS intervention on falls self-efficacy (fear of falling)

    Change from initial assessment to 6 months

  • To determine the effect of the eSTEPS intervention on self-efficacy for exercise

    Change from initial visit to 6 months

Other Outcomes (2)

  • To explore the effect of the eSTEPS intervention on the rate of death

    Up to 23 months

  • To determine the effect of the eSTEPS intervention the rate of fall injuries

    Up to 23 months

Study Arms (2)

eSTEPS Clinical Decision Support

EXPERIMENTAL

Use of clinical decision support to assist in exercise-related fall prevention care planning will be compared to usual care.

Behavioral: eSTEPS CDS

Usual Care

NO INTERVENTION

Usual primary care practices regarding exercise-related fall prevention planning

Interventions

eSTEPS CDSBEHAVIORAL

Primary care clinics at Brigham and Women's Hospital will be randomized to receive the eSTEPS CDS or usual care. The University of Texas Medical Branch (UTMB) will be the replication site, with all participating primary care practices receiving the eSTEPS CDS.

eSTEPS Clinical Decision Support

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Age 65 or above
  • Patients enrolled in participating primary care intervention and control practices at MGB or enrolled in participating primary care replication trial intervention practices at UTMB
  • Positive screen for fall risk at annual wellness visit

You may not qualify if:

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • \- Not community-dwelling (i.e. residents of long-term care facilities, prisoners etc.)
  • Enrollment in the Subsample for Patient Reported Outcomes (PROs):
  • Unwilling or unable to provide verbal consent
  • Not able to participate due to cognitive impairment (i.e., 4 or more errors on the Callahan Cognitive Screen assessment)
  • Has a terminal illness or other condition that indicates that the participant is not expected to survive for 1 year, such as receiving hospice or palliative care services.
  • Not fluent in spoken English
  • Does not have access to a working telephone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The design is a cluster randomized, parallel group superiority trial with practices stratified by healthcare system and patients nested within practices. The unit of randomization is the practice.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

June 22, 2021

First Posted

August 6, 2021

Study Start

June 8, 2023

Primary Completion

May 8, 2025

Study Completion

August 31, 2025

Last Updated

February 11, 2026

Record last verified: 2025-12

Locations